Health News

GSK to produce 60 million Novavax doses for Britain

GlaxoSmithKline is to manufacture 60 million doses of the COVID-19 vaccine developed by US biotech company Novavax for UK distribution, the British pharmaceutical giant said in a statement Monday. A statement from the company said they had reached an “agreement in principe” to make the doses at a plant in the northeast of England “beginning […]